Skip to main content

FDA Updates

FDA-Approved Nirogacestat Demonstrates Improved Patient Outcomes in Desmoid Tumor Management

Jerm Day-Storms, PhD, MWC

Iwilfin FDA Approved for Adults and Pediatric Patients with High-Risk Neuroblastoma

Welireg Now FDA Approved for Patients with Advanced Renal Cell Carcinoma

Keytruda Plus Chemotherapy Receives New FDA Approvals for Advanced Biliary Tract Cancer and 2 Forms of Advanced Gastroesophageal Junction Adenocarcinoma

FDA Approved Loqtorzi, a PD-1 Inhibitor, for the Treatment of Adults With Metastatic or Recurrent Nasopharyngeal Carcinoma

Tibsovo FDA Approved for Patients With Relapsed Myelodysplastic Syndromes and IDH1 Mutation

Fruzaqla FDA Approved for Refractory Metastatic Colorectal Cancer

Rozlytrek Now Approved for Pediatric Patients Older Than 1 Month With Solid Tumors and NTRK Gene Fusion and in New Oral Pellet Form

FDA Authorizes Updated COVID-19 Vaccine Formulations for Better Protection Against Current Variants

Bosulif Now FDA Approved for Pediatric Patients With Chronic Myelogenous Leukemia

1
2
3
4

Page 1 of 33
Results 1 - 10 of 330